Global Pipeline Embolization Device (PED) Market Growth 2025-2031

Publication ID:

LPI04252228

Publication Date:

April 25, 2025

Pages:

115

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Pipeline Embolization Device (PED) market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
The 鈥淧ipeline Embolization Device (PED) Industry Forecast鈥� looks at past sales and reviews total world Pipeline Embolization Device (PED) sales in 2024, providing a comprehensive analysis by region and market sector of projected Pipeline Embolization Device (PED) sales for 2025 through 2031. With Pipeline Embolization Device (PED) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pipeline Embolization Device (PED) industry.
This Insight Report provides a comprehensive analysis of the global Pipeline Embolization Device (PED) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pipeline Embolization Device (PED) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Pipeline Embolization Device (PED) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pipeline Embolization Device (PED) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pipeline Embolization Device (PED).
This report presents a comprehensive overview, market shares, and growth opportunities of Pipeline Embolization Device (PED) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
48 Alloy Wire Braided
64 Alloy Wire Braided
Other
Segmentation by Application:
Intracranial Aneurysm Treatment
Neurovascular Abnormal Embolization Treatment (Arteriovenous Malformation, etc.)
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Medtronic
MicroPort
Stryker Corporation
Microvention
Codman
Boston Scientific
Balt Extrusion
Phenox GmbH
Johnson & Johnson
Ascendis Health
ZYLOX-TONBRIDGE
Accumedical
Evasc
Key Questions Addressed in this Report
What is the 10-year outlook for the global Pipeline Embolization Device (PED) market?
What factors are driving Pipeline Embolization Device (PED) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pipeline Embolization Device (PED) market opportunities vary by end market size?
How does Pipeline Embolization Device (PED) break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pipeline Embolization Device (PED) Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Pipeline Embolization Device (PED) by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Pipeline Embolization Device (PED) by Country/Region, 2020, 2024 & 2031
2.2 Pipeline Embolization Device (PED) Segment by Type
2.2.1 48 Alloy Wire Braided
2.2.2 64 Alloy Wire Braided
2.2.3 Other
2.3 Pipeline Embolization Device (PED) Sales by Type
2.3.1 Global Pipeline Embolization Device (PED) Sales Market Share by Type (2020-2025)
2.3.2 Global Pipeline Embolization Device (PED) Revenue and Market Share by Type (2020-2025)
2.3.3 Global Pipeline Embolization Device (PED) Sale Price by Type (2020-2025)
2.4 Pipeline Embolization Device (PED) Segment by Application
2.4.1 Intracranial Aneurysm Treatment
2.4.2 Neurovascular Abnormal Embolization Treatment (Arteriovenous Malformation, etc.)
2.4.3 Other
2.5 Pipeline Embolization Device (PED) Sales by Application
2.5.1 Global Pipeline Embolization Device (PED) Sale Market Share by Application (2020-2025)
2.5.2 Global Pipeline Embolization Device (PED) Revenue and Market Share by Application (2020-2025)
2.5.3 Global Pipeline Embolization Device (PED) Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Pipeline Embolization Device (PED) Breakdown Data by Company
3.1.1 Global Pipeline Embolization Device (PED) Annual Sales by Company (2020-2025)
3.1.2 Global Pipeline Embolization Device (PED) Sales Market Share by Company (2020-2025)
3.2 Global Pipeline Embolization Device (PED) Annual Revenue by Company (2020-2025)
3.2.1 Global Pipeline Embolization Device (PED) Revenue by Company (2020-2025)
3.2.2 Global Pipeline Embolization Device (PED) Revenue Market Share by Company (2020-2025)
3.3 Global Pipeline Embolization Device (PED) Sale Price by Company
3.4 Key Manufacturers Pipeline Embolization Device (PED) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pipeline Embolization Device (PED) Product Location Distribution
3.4.2 Players Pipeline Embolization Device (PED) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Pipeline Embolization Device (PED) by Geographic Region
4.1 World Historic Pipeline Embolization Device (PED) Market Size by Geographic Region (2020-2025)
4.1.1 Global Pipeline Embolization Device (PED) Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Pipeline Embolization Device (PED) Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Pipeline Embolization Device (PED) Market Size by Country/Region (2020-2025)
4.2.1 Global Pipeline Embolization Device (PED) Annual Sales by Country/Region (2020-2025)
4.2.2 Global Pipeline Embolization Device (PED) Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pipeline Embolization Device (PED) Sales Growth
4.4 APAC Pipeline Embolization Device (PED) Sales Growth
4.5 Europe Pipeline Embolization Device (PED) Sales Growth
4.6 Middle East & Africa Pipeline Embolization Device (PED) Sales Growth
5 Americas
5.1 Americas Pipeline Embolization Device (PED) Sales by Country
5.1.1 Americas Pipeline Embolization Device (PED) Sales by Country (2020-2025)
5.1.2 Americas Pipeline Embolization Device (PED) Revenue by Country (2020-2025)
5.2 Americas Pipeline Embolization Device (PED) Sales by Type (2020-2025)
5.3 Americas Pipeline Embolization Device (PED) Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pipeline Embolization Device (PED) Sales by Region
6.1.1 APAC Pipeline Embolization Device (PED) Sales by Region (2020-2025)
6.1.2 APAC Pipeline Embolization Device (PED) Revenue by Region (2020-2025)
6.2 APAC Pipeline Embolization Device (PED) Sales by Type (2020-2025)
6.3 APAC Pipeline Embolization Device (PED) Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Pipeline Embolization Device (PED) by Country
7.1.1 Europe Pipeline Embolization Device (PED) Sales by Country (2020-2025)
7.1.2 Europe Pipeline Embolization Device (PED) Revenue by Country (2020-2025)
7.2 Europe Pipeline Embolization Device (PED) Sales by Type (2020-2025)
7.3 Europe Pipeline Embolization Device (PED) Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pipeline Embolization Device (PED) by Country
8.1.1 Middle East & Africa Pipeline Embolization Device (PED) Sales by Country (2020-2025)
8.1.2 Middle East & Africa Pipeline Embolization Device (PED) Revenue by Country (2020-2025)
8.2 Middle East & Africa Pipeline Embolization Device (PED) Sales by Type (2020-2025)
8.3 Middle East & Africa Pipeline Embolization Device (PED) Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pipeline Embolization Device (PED)
10.3 Manufacturing Process Analysis of Pipeline Embolization Device (PED)
10.4 Industry Chain Structure of Pipeline Embolization Device (PED)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pipeline Embolization Device (PED) Distributors
11.3 Pipeline Embolization Device (PED) Customer
12 World Forecast Review for Pipeline Embolization Device (PED) by Geographic Region
12.1 Global Pipeline Embolization Device (PED) Market Size Forecast by Region
12.1.1 Global Pipeline Embolization Device (PED) Forecast by Region (2026-2031)
12.1.2 Global Pipeline Embolization Device (PED) Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Pipeline Embolization Device (PED) Forecast by Type (2026-2031)
12.7 Global Pipeline Embolization Device (PED) Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic Pipeline Embolization Device (PED) Product Portfolios and Specifications
13.1.3 Medtronic Pipeline Embolization Device (PED) Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 MicroPort
13.2.1 MicroPort Company Information
13.2.2 MicroPort Pipeline Embolization Device (PED) Product Portfolios and Specifications
13.2.3 MicroPort Pipeline Embolization Device (PED) Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 MicroPort Main Business Overview
13.2.5 MicroPort Latest Developments
13.3 Stryker Corporation
13.3.1 Stryker Corporation Company Information
13.3.2 Stryker Corporation Pipeline Embolization Device (PED) Product Portfolios and Specifications
13.3.3 Stryker Corporation Pipeline Embolization Device (PED) Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Stryker Corporation Main Business Overview
13.3.5 Stryker Corporation Latest Developments
13.4 Microvention
13.4.1 Microvention Company Information
13.4.2 Microvention Pipeline Embolization Device (PED) Product Portfolios and Specifications
13.4.3 Microvention Pipeline Embolization Device (PED) Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Microvention Main Business Overview
13.4.5 Microvention Latest Developments
13.5 Codman
13.5.1 Codman Company Information
13.5.2 Codman Pipeline Embolization Device (PED) Product Portfolios and Specifications
13.5.3 Codman Pipeline Embolization Device (PED) Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Codman Main Business Overview
13.5.5 Codman Latest Developments
13.6 Boston Scientific
13.6.1 Boston Scientific Company Information
13.6.2 Boston Scientific Pipeline Embolization Device (PED) Product Portfolios and Specifications
13.6.3 Boston Scientific Pipeline Embolization Device (PED) Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Boston Scientific Main Business Overview
13.6.5 Boston Scientific Latest Developments
13.7 Balt Extrusion
13.7.1 Balt Extrusion Company Information
13.7.2 Balt Extrusion Pipeline Embolization Device (PED) Product Portfolios and Specifications
13.7.3 Balt Extrusion Pipeline Embolization Device (PED) Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Balt Extrusion Main Business Overview
13.7.5 Balt Extrusion Latest Developments
13.8 Phenox GmbH
13.8.1 Phenox GmbH Company Information
13.8.2 Phenox GmbH Pipeline Embolization Device (PED) Product Portfolios and Specifications
13.8.3 Phenox GmbH Pipeline Embolization Device (PED) Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Phenox GmbH Main Business Overview
13.8.5 Phenox GmbH Latest Developments
13.9 Johnson & Johnson
13.9.1 Johnson & Johnson Company Information
13.9.2 Johnson & Johnson Pipeline Embolization Device (PED) Product Portfolios and Specifications
13.9.3 Johnson & Johnson Pipeline Embolization Device (PED) Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Johnson & Johnson Main Business Overview
13.9.5 Johnson & Johnson Latest Developments
13.10 Ascendis Health
13.10.1 Ascendis Health Company Information
13.10.2 Ascendis Health Pipeline Embolization Device (PED) Product Portfolios and Specifications
13.10.3 Ascendis Health Pipeline Embolization Device (PED) Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Ascendis Health Main Business Overview
13.10.5 Ascendis Health Latest Developments
13.11 ZYLOX-TONBRIDGE
13.11.1 ZYLOX-TONBRIDGE Company Information
13.11.2 ZYLOX-TONBRIDGE Pipeline Embolization Device (PED) Product Portfolios and Specifications
13.11.3 ZYLOX-TONBRIDGE Pipeline Embolization Device (PED) Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 ZYLOX-TONBRIDGE Main Business Overview
13.11.5 ZYLOX-TONBRIDGE Latest Developments
13.12 Accumedical
13.12.1 Accumedical Company Information
13.12.2 Accumedical Pipeline Embolization Device (PED) Product Portfolios and Specifications
13.12.3 Accumedical Pipeline Embolization Device (PED) Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Accumedical Main Business Overview
13.12.5 Accumedical Latest Developments
13.13 Evasc
13.13.1 Evasc Company Information
13.13.2 Evasc Pipeline Embolization Device (PED) Product Portfolios and Specifications
13.13.3 Evasc Pipeline Embolization Device (PED) Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Evasc Main Business Overview
13.13.5 Evasc Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂